Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Volume 51 Issue 6, June 2019

Building links between chromatin and metabolism

This artistic rendering depicts a role for folate metabolism in BRD4-mediated transcription. The folate metabolic enzyme MTHFD1 is recruited to chromatin through physical interaction with BRD4. Through its enzymatic activity, MTHFD1 provides one-carbon intermediates, which form the building blocks for several important metabolite classes in the nucleus, including purines, which are incorporated into RNA during transcription.

See Sdelci et al.

Image: Artwork by Mariangela Corsetti. Cover Design: Marina Spence.

Editorial

  • In the field of infectious diseases, genomics can be a useful tool for guiding vaccine development. Given the inevitability and increasing prevalence of antibiotic resistance, vaccines against pathogenic microbes can be even more valuable than antibiotics as a strategy to prevent serious or deadly infectious diseases. Genomic resources from global analysis of large numbers of clinical isolates can serve as a basis for identifying appropriate candidates for vaccine antigens, and we encourage continued efforts in the generation of pan-genome sequences for bacterial or viral pathogens.

    Editorial

    Advertisement

Top of page ⤴

Comment

  • The Nordic region, comprising primarily Denmark, Estonia, Finland, Iceland, Norway and Sweden, has many of the necessary characteristics for being at the forefront of genome-based precision medicine. These include egalitarian and universal healthcare, expertly curated patient and population registries, biobanks, large population-based prospective cohorts linked to registries and biobanks, and a widely embraced sense of social responsibility that motivates public engagement in biomedical research. However, genome-based precision medicine can be achieved only through coordinated action involving all actors in the healthcare sector. Now is an opportune time to organize scientists in the Nordic region, together with other stakeholders including patient representatives, governments, pharmaceutical companies, academic institutions and funding agencies, to initiate a Nordic Precision Medicine Initiative. We present a roadmap for how this organization can be created. The Initiative should facilitate research, clinical trials and knowledge transfer to meet regional and global health challenges.

    • Pål Rasmus Njølstad
    • Ole Andreas Andreassen
    • Kári Stefánsson
    Comment
Top of page ⤴

News & Views

  • Epigenetic heterogeneity underlies the diversity of cell states found in health and disease. A new study presents a method for profiling of histone modifications in single cells and applies it to identify rare chromatin states, possibly predisposed to drug resistance, within patient-derived tumor xenografts.

    • Anna Minkina
    • Jay Shendure
    News & Views
Top of page ⤴

Letters

Top of page ⤴

Articles

Top of page ⤴

Technical Reports

Top of page ⤴

Amendments & Corrections

Top of page ⤴

Search

Quick links